Class IIOngoing
Biomerieux Inc recalls VITEK 2 AST-N447 TEST KIT Product reference 424620
Recall date · record updated Jul 15, 2026 · Source: U.S. Food and Drug Administration (openFDA device enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- Biomerieux Inc
- Reason
- Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- International distribution to the countries of Belgium and the Netherlands.
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99213…
Products
VITEK 2 AST-N447 TEST KIT Product reference 424620
Codes/lots: Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.Quantity: 45,900 cardsRecall no. Z-2715-2026Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass I
Par Health USA, LLC recalls 2 products
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
· FDA · Nationwide
Medicines & devicesClass II
Right Value Drug Stores LLC recalls Testosterone Cypionate
Lack of sterility assurance.
· FDA · Nationwide
Medicines & devicesClass II
STRIDES PHARMA INC recalls Cinacalcet Tablets
Failed dissolution specifications
· FDA · Nationwide